Evident Vascular
Evident Vascular, Inc. is a San Jose, California medical device company developing the Evident Vascular Guidance System, an AI-powered intravascular ultrasound (IVUS) platform purpose-built for peripheral vascular image-guided therapy, with future capability intended for coronary procedures. The company came out of stealth in 2023 with a $35M Series A led by Vensana Capital and closed a Series B in March 2025 with Shangbay Capital and strategic investors, funding work toward FDA 510(k) clearance and a U.S. launch. The platform pairs an IVUS catheter and console with machine-learning image interpretation intended to improve vessel assessment and streamline the interventional workflow. Evident Vascular is pre-commercial and publishes no developer program, API, SDK, or machine-readable interface on its public web surface.
Evident Vascular is profiled on the APIs.io network. Tagged areas include Company, Medical Devices, Health, Imaging, and Artificial Intelligence.
Evident Vascular’s developer surface includes engineering blog, support, and 9 more developer resources.
Kin Score
Pricing Plans 1
Published pricing tiers and plan structures.
Rate Limits 1
Documented rate limits and quota policies.
Evident Vascular Rate Limits
RATE LIMITSSecurity Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Agent Surfaces 1
MCP servers, agent skills, and machine-readable catalogs
Access & Security 1
Authentication, authorization, and security posture
Operate 2
Status, limits, changes, and where to get help
Commercial 3
Pricing, plans, and the legal terms of use
Company 4
The organization behind the API